Arlington Trust Co LLC
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1997685
BIRMINGHAM, AL
Position in REGN
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$2,494
-$596 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,289
of 1,320 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Arlington Trust Co LLC holds $90,695 across 9 Biotechnology names. REGN ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
97 | $48,182 | |
| 2 | ARGX |
Argenx SE
|
24 | $22,266 | |
| 3 | INSM |
INSMED Inc
|
44 | $4,691 | |
| 4 | BNTX |
BioNTech SE
|
50 | $4,652 | |
| 5 | MRNA |
Moderna, Inc.
|
60 | $4,201 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
4 | $2,494 | |
| 7 | CYTK |
Cytokinetics Inc
|
21 | $1,788 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
28 | $1,762 |
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,494 | 4 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $3,090 | 4 | Shares | Sole | 2026-04-08 | |
| 2025-09-30 | $78,717 | 140 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $73,500 | 140 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $88,792 | 140 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $99,726 | 140 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $147,173 | 140 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $147,144 | 140 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $6,148 | 7 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $2,468 | 3 | Shares | Sole | 2023-10-24 | |
| No filing history on record for this holder in this stock. | ||||||